Regarding the Consensus Statement on 21-Hydroxylase Deficiency from the Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology (original) (raw)

This paper presents the consensus statement from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology regarding the management of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Emphasizing a multidisciplinary approach, the guidelines address areas from neonatal diagnosis to adult management, acknowledging gaps in current knowledge and promoting early diagnosis and optimal treatment strategies. Emerging therapies require evaluation before routine application, with the recognition of the importance of coordination among healthcare professionals.